Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > 980 CKNW - Mornings with Simi - Interview with Roger

<< Previous

Bullboard Posts

Next >>

Comment by DeathXray33on Jul 09, 2023 8:12pm

270 Views

Post# 35533000

RE:RE:RE:RE:RE:980 CKNW - Mornings with Simi - Interview with Roger

Legit62 wrote: Ya you would think that if he would keep things toned down a bit until FDA gives us the nod, well we might be hearing something very very soon as possibly tomorrow news release, just IMO , but he does sound super positive throwing the word cure out

Didn't everyone do their due diligence on the Anti-Cancer Vaccine here??? Sigh... "This new research demonstrates that the Theralase anti-cancer vaccine approach is not limited to any specific type of cancer and is thus able to be adapted to be effective for the treatment of various cancers.''

<< Previous

Bullboard Posts

Next >>

Osisko Development receives permits for Cariboo Gold Project